mvtpharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.mvtpharma.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change
Meta Tags
Title MVT Pharma: Pioneers in ultrasound contrast and
Description Microvascular Therapeutics (MVT) is a biotechnology company specializing in the development of microbubble and nanotechnology products for the diagnosis and treatment of
Keywords N/A
Server Information
WebSite mvtpharma faviconmvtpharma.com
Host IP 23.236.62.147
Location United States
Related Websites
Site Rank
More to Explore
mvtpharma.com Valuation
US$1,657,339
Last updated: 2023-05-08 08:25:07

mvtpharma.com has Semrush global rank of 6,386,327. mvtpharma.com has an estimated worth of US$ 1,657,339, based on its estimated Ads revenue. mvtpharma.com receives approximately 191,232 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, mvtpharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,657,339
Daily Ads Revenue US$1,530
Monthly Ads Revenue US$45,896
Yearly Ads Revenue US$550,747
Daily Unique Visitors 12,749
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
mvtpharma.com. A 599 IP: 23.236.62.147
mvtpharma.com. NS 3600 NS Record: ns36.domaincontrol.com.
mvtpharma.com. NS 3600 NS Record: ns35.domaincontrol.com.
mvtpharma.com. MX 3600 MX Record: 0 mvtpharma-com.mail.protection.outlook.com.
mvtpharma.com. TXT 3600 TXT Record: NETORGFT3674203.onmicrosoft.com
mvtpharma.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-08 08:25:07
top of page HOME TEAM NEWS JOURNALS CAREERS CONTACT Follow Us Pioneers in ultrasound contrast and theranostics. FOLLOW US Moving forward MVT has developed a new, patented formulation, MVT-100 , for use as an ultrasound contrast agent. MVT-100 has a neutral surface chemistry, potentially serving as a platform for development of agents for molecular imaging and image-guided therapy. We’ve received formal guidance from the FDA that MVT-100 can be developed via the 505(b)(2) pathway. The Company has designed an accelerated development pathway to potentially lead to approval of MVT-100 for echocardiography. Momentum with MVT–100 PHASE 1 & 2 MVT–100 ​ Indication: Echocardiography ​ 505b Pathway — Accelerated approval. Patent granted for improved microbubble formulation. PRE-CLINICAL MVT–101 ​ Indication: Sono​thrombolysis - DVT, PE, ALI ​ MVT has right of reference to data showing efficacy of microbubble enhance sonothrombolysis using perflutren. MVT has exclusive right to condensed Phase
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 29 Oct 2021 16:41:42 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.mvtpharma.com/
strict-transport-security: max-age=120
Age: 64253
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVihnQVYpfofwhBhTRHXuy5t,m0j2EEknGIVUW/liY8BLLnA6bACTJOyhQFe80epZkoEa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalqFEvHPUQKgBVDebFIt85DHYbY9NLkieCm2Uzlal9/K7CBdH/AI/HGCkV6ltRKa+zQ==,2UNV7KOq4oGjA5+PKsX47DqQgZ4euQCNWDy58PBtjlYfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1635525702.61776418795133283
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Fri, 29 Oct 2021 16:41:42 GMT
content-type: text/html; charset=UTF-8
content-length: 439829
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"fe61dae067fd1eb37b7ab203c8303686"
content-language: en
strict-transport-security: max-age=120
age: 248966
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Tue, 26 Oct 2021 19:32:36 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YVbPKomdLHJrTNNDJpklqig=,gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgLJDAhu8NTMTGQmks8KvGA,m0j2EEknGIVUW/liY8BLLl5lGwBvY6S6kqNcXrlzUhEO5u3dMxPR3QRc6kpLZVuH,2d58ifebGbosy5xc+FRalgw4aDraILIn+jgAvY6q0EU24Eq8r6vD3qF8jl/ysHvZfVDWWVdryuuWkq/vyLnRhg==,2UNV7KOq4oGjA5+PKsX47O2a5xgRLfGhgyjJBLXaH1ZYgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635525702.8567631285677626207
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131fd83bdfaf304227d3d3077db66e5f4791fb950bfd3211aa4366f4674e3fda4aefc31ec2f21b344f281a13f09ba719ed7; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10
mvtpharma.com Whois Information
Domain Name: MVTPHARMA.COM
Registry Domain ID: 2213187690_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2019-03-22T16:49:30Z
Creation Date: 2018-01-14T23:26:41Z
Registry Expiry Date: 2023-01-14T23:26:41Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS35.DOMAINCONTROL.COM
Name Server: NS36.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T05:31:00Z <<<

Copyright © 2022 WebZZ.US 0.0223